Dobutamine and Nitroglycerine versus Milrinone for Perioperative Management of Pulmonary Hypertension in Mitral Valve Surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201710002685398

Enrollment

Registered

2017-10-12

Start date

2015-05-02

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery anesthesia Anaesthesia

Interventions

doputamine & nitroglycerine

milrinone

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The inclusion criteria were patients with mitral valve disease aged between 22 to 45 years old of both sexes having PAP ranged from 65 to 110 mmHg and scheduled for elective mitral valve replacement.

Exclusion criteria

Exclusion criteria: The Exclusion criteria were patients with Severely reduced myocardial function i.e. left ventricular ejection fraction 2.0 mmol/L), Severe chest disease or COPD patients, Pulmonary valve disease or replacement, Recent pacemaker insertion, left bundle branch block, Wolf Parkinson-White Syndrome or Ebstein¿s anomaly and Recent stroke.

Design outcomes

Primary

Measure	Time frame
mean pulmonary artery pressure	—

Secondary

Measure	Time frame
hemodynamic parameters(heart rate&blood pressure)	—

Countries

Egypt

Contacts

Public Contactahmed abd elraouf

professor of anesthesia, menoufiya faculty of medicine

ahmedabdelraoufmetwally@yahoo.com00201227968325

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026